Associate Professor Satzke obtained her PhD in molecular microbiology from The University of Melbourne in 2007. She then established a microbiological research laboratory at the Murdoch Children's Research Institute within the Pneumococcal Research Group led by Prof Kim Mulholland.
Associate Professor Satzke led a project funded by the Bill and Melinda Gates Foundation which involved over 20 international collaborators. She has since attracted further funds to establish two serotype reference centres, facilitating vaccine impact studies in Asia. She led the update of World Health Organization (WHO) standards for pneumococcal carriage studies and made important contributions to studies in Fiji, leading to vaccination introduction.
Associate Professor Satzke has been an investigator on grants totalling $39.7 million, notably $3.1 million as co-principal investigator on a Bill and Melinda Gates Foundation grant. A/Prof Satzke received the inaugural Veski Inspiring Women Fellowship (2015-), the prestigious international Robert Austrian Research award (2012), has been an invited speaker at six international conferences and co-organised a WHO meeting.
Associate Professor Satzke has published in journals including PLOS Medicine, Lancet, Vaccine and PLOS Pathogens. She currently supervises two post-doctoral researchers, five research assistants, one administrator, two PhD and one Honours student, and regularly hosts Masters students. Associate Professor Satzke was named MCRI's supervisor of the year in 2013.
Associate Professor Satzke obtained her PhD in molecular microbiology from The University of Melbourne in 2007. She then established a microbiological research laboratory at the Murdoch Children's Research Institute within the Pneumococcal Research...
Associate Professor Satzke obtained her PhD in molecular microbiology from The University of Melbourne in 2007. She then established a microbiological research laboratory at the Murdoch Children's Research Institute within the Pneumococcal Research Group led by Prof Kim Mulholland.
Associate Professor Satzke led a project funded by the Bill and Melinda Gates Foundation which involved over 20 international collaborators. She has since attracted further funds to establish two serotype reference centres, facilitating vaccine impact studies in Asia. She led the update of World Health Organization (WHO) standards for pneumococcal carriage studies and made important contributions to studies in Fiji, leading to vaccination introduction.
Associate Professor Satzke has been an investigator on grants totalling $39.7 million, notably $3.1 million as co-principal investigator on a Bill and Melinda Gates Foundation grant. A/Prof Satzke received the inaugural Veski Inspiring Women Fellowship (2015-), the prestigious international Robert Austrian Research award (2012), has been an invited speaker at six international conferences and co-organised a WHO meeting.
Associate Professor Satzke has published in journals including PLOS Medicine, Lancet, Vaccine and PLOS Pathogens. She currently supervises two post-doctoral researchers, five research assistants, one administrator, two PhD and one Honours student, and regularly hosts Masters students. Associate Professor Satzke was named MCRI's supervisor of the year in 2013.
Top Publications
von Mollendorf, C, Ulziibayar, M, Gessner, BD, Do, LAH, Nguyen, CD, Beavon, R, Suuri, B, Luvsantseren, D, Narangerel, D, Jenney, A, et al.
Evaluation of the impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia in Ulaanbaatar, Mongolia: study protocol for an observational study..
BMC Public Health
21(1)
:
1731
2021
view publication
Britton, KJ, Pickering, JL, Pomat, WS, de Gier, C, Nation, ML, Pell, CL, Granland, CM, Solomon, V, Ford, RL, Greenhill, A, et al.
Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants..
Vaccine
39(38)
:
5401 -5409
2021
view publication
von Mollendorf, C, Lim, R, Choummanivong, M, Sychareun, V, Vilivong, K, Lai, JYR, Chan, J, Dunne, EM, Phommachanh, S, Moore, K, et al.
370Measuring pneumococcal conjugate vaccine impact in a low-resource setting with minimal baseline data.
International Journal of Epidemiology
50(Supplement_1)
:
dyab168.687-
2021
view publication
Chan, J, Lai, JYR, Nguyen, CD, Vilivong, K, Dunne, EM, Dubot-Pérès, A, Fox, K, Hinds, J, Moore, KA, Nation, ML, et al.
Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People's Democratic Republic..
BMJ Glob Health
6(6)
:
2021
view publication
Temple, B, Nation, ML, Dai, VTT, Beissbarth, J, Bright, K, Dunne, EM, Hinds, J, Hoan, PT, Lai, J, Nguyen, CD, et al.
Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage: Results from a randomised controlled trial in Vietnam..
Vaccine
39(16)
:
2303 -2310
2021
view publication